MDoutlook has extensive experience in analyzing the European cancer market, focusing on both solid and liquid tumors. In the last few years, MDoutlook provided more than 30 clients with answers to who, what, when, where, and why of cancer treatment in Europe.

Recent work addressed business critical issues in:

  • Major malignancies: breast, colorectal, lung, melanoma, prostate, CLL, NHL
  • Targeted malignancies: liver, thyroid, ALL, HL and others
  • Management of cancer: market access, supportive care, management of adverse events

Insight from a recent European study in Chronic Lymphocytic Leukemia (CLL | n=100) prompted further analysis shared below:

Unmet needs as reported by 100 medical oncologists  from the EU5

Unmet needs as reported by 100 medical oncologists from the EU5

Contact us to discuss how MDoutlook can support your disease intelligence needs, through customized and syndicated studies, ThoughtLeader identification and physician engagement.